Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 12Active not recruiting 5Completed 3Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1

Interventions

pembrolizumab 66Cyclophosphamide 44Cisplatin 43Nivolumab 36Paclitaxel 32Carboplatin 31Radiotherapy 29Gemcitabine 28Docetaxel 25Dexamethasone 22atezolizumab 21Doxorubicin 19Bevacizumab 19Magnetic Resonance Spectroscopy 17fludarabine 16Vincristine 16Lenalidomide 16Etoposide 16Radiosurgery 15Letrozole 15Ipilimumab 15Fluorouracil 15Blood Specimen Collection 15palbociclib 14Rituximab 14Radiation 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13Specimen Handling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × sotorasib × 90 days × Clear all
NCT04380753 2026-05-06

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Amgen

Phase 1 Completed
12 enrolled 12 charts
Other solid neoplasm

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

NCT05198934 2026-04-27

CodeBreak300

Amgen

Phase 3 Completed
160 enrolled 1 FDA
Gastrointestinal

Colorectal Neoplasms

NCT07143513 2026-04-07

Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

Amgen

Completed
102 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡